Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TEMPE, Ariz., May 6, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company") will host a conference call and webcast presenting first quarter 2009...
-
TEMPE, Ariz., April 22, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) today announced publication of results from the second data group of a pre-clinical study demonstrating that...
-
TEMPE, Ariz., April 3, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the initiation of dosing for its AZX100 Phase 2 pilot clinical trial in keloid scarring. The Phase...
-
TEMPE, Ariz., March 5, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) today announced publication of results from the first data group of a pre-clinical study demonstrating that...
-
TEMPE, Ariz., Feb. 10, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the initiation of dosing for its AZX100 Phase 2 clinical trial in dermal scarring. The clinical...
-
TEMPE, Ariz, Feb. 5, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) will host a teleconference and webcast to discuss operating plans on Tuesday, February 10, 2009 at 4:30pm EST/ 3:30pm...
-
TEMPE, Ariz., Dec. 15, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the publication of several abstracts characterizing the science of its novel thrombin peptide...
-
TEMPE, Ariz., Dec. 10, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today positive safety results were obtained in the second of two planned Phase 1 human clinical trials of...
-
TEMPE, Ariz., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the third quarter 2008. The...
-
TEMPE, Ariz., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. ("the Company"), received on August 11, 2008 a letter dated August 8, 2008 from The...